Edwards Lifesciences Corp Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Edwards Lifesciences Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2010 to Q3 2024.
  • Edwards Lifesciences Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $35.2M, a 21% increase year-over-year.
  • Edwards Lifesciences Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $155M, a 19.6% increase year-over-year.
  • Edwards Lifesciences Corp annual Share-based Payment Arrangement, Expense for 2023 was $139M, a 9.94% increase from 2022.
  • Edwards Lifesciences Corp annual Share-based Payment Arrangement, Expense for 2022 was $127M, a 16% increase from 2021.
  • Edwards Lifesciences Corp annual Share-based Payment Arrangement, Expense for 2021 was $109M, a 18% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $155M $35.2M +$6.1M +21% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $149M $37.5M +$3.8M +11.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $145M $44.6M +$5.7M +14.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $139M $37.7M +$9.8M +35.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-12
Q3 2023 $130M $29.1M -$1.2M -3.96% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $131M $33.7M -$2.5M -6.91% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-31
Q1 2023 $133M $38.9M +$6.5M +20.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-29
Q4 2022 $127M $27.9M +$3.7M +15.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-12
Q3 2022 $123M $30.3M +$3.7M +13.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 $119M $36.2M +$5.9M +19.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-28
Q1 2022 $114M $32.4M +$4.2M +14.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $109M $24.2M +$3.3M +15.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-12
Q3 2021 $106M $26.6M +$3.6M +15.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $102M $30.3M +$5.5M +22.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $96.9M $28.2M +$4.3M +18% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $92.6M $20.9M +$2.5M +13.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-13
Q3 2020 $90.1M $23M +$3.2M +16.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $86.9M $24.8M +$2.5M +11.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $84.4M $23.9M +$3.1M +14.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $81.3M $18.4M +$3.2M +21.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-14
Q3 2019 $78.1M $19.8M +$2.4M +13.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-26
Q2 2019 $75.7M $22.3M +$3.1M +16.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-27
Q1 2019 $72.6M $20.8M +$1.6M +8.33% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-28
Q4 2018 $71M $15.2M -$100K -0.65% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $71.1M $17.4M +$1.6M +10.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $69.5M $19.2M +$3.9M +25.5% Apr 1, 2018 Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $65.6M $19.2M +$4M +26.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-07-26
Q4 2017 $61.6M $15.3M +$1.4M +10.1% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $60.2M $15.8M +$1.4M +9.72% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $58.8M $15.3M +$1M +6.99% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $57.8M $15.2M +$900K +6.29% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $56.9M $13.9M +$1M +7.75% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 $55.9M $14.4M +$1.8M +14.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-27
Q2 2016 $54.1M $14.3M +$3.5M +32.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $50.6M $14.3M +$700K +5.15% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $49.9M $12.9M +$700K +5.74% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $49.2M $12.6M +$400K +3.28% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $48.8M $10.8M -$1.1M -9.24% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $49.9M $13.6M +$1.6M +13.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $48.3M $12.2M +$700K +6.09% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $47.6M $12.2M +$300K +2.52% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 $47.3M $11.9M -$900K -7.03% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-29
Q1 2014 $48.2M $12M +$800K +7.14% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 $47.4M $11.5M +$700K +6.48% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $46.7M $11.9M +$1M +9.17% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 $45.7M $12.8M +$1.6M +14.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 $44.1M $11.2M +$2M +21.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $42.1M $10.8M +$1.8M +20% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $40.3M $10.9M +$400K +3.81% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 $39.9M $11.2M +$3.4M +43.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $36.5M $9.2M +$1.5M +19.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-06
Q4 2011 $35M $9M +$2.1M +30.4% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $32.9M $10.5M +$1.9M +22.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $31M $7.8M +$1.5M +23.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $29.5M $7.7M +$200K +2.67% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 $29.3M $6.9M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 $8.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 $6.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $7.5M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.